Epidermal growth factor activation of NF-kappaB is mediated through IkappaBalpha degradation and intracellular free calcium.

Abstract:

:The transcription factor NF-kappa-B is normally sequestered in the cytoplasm by its inhibitory subunit IkappaB. Most extracellular signals activate NF-kappa-B through a mechanism involving the phosphorylation and proteasome-dependent degradation of IkappaB. EGF activates NF-kappaB in A-431 carcinoma cells, which overexpress EGF receptors and in mouse embryo fibroblasts, which have a normal complement of receptors. Supershift experiments indicate that the NF-kappa-B complexes induced by EGF are composed of p50/p50 homodimers and p65/p50 heterodimers, but not c-rel. EGF stimulation enhances the degradation of IkappaBalpha, but not IkappaBbeta nor an N-terminal deletion mutant of IkappaBalpha. Treatment of cells with a proteasome inhibitor, such as ALLN or MG132, blocks EGF-mediated NF-kappaB activation, indicating that EGF-induced NF-kappa-B activation requires proteasome-dependent IkappaB degradation. Also, Bapta A/M (a cell-permeable chelator of intracellular calcium) blocks EGF-induced NF-kappa-B activation and IkappaBalpha degradation, suggesting a requirement of intracellular free Ca2+ for this growth factor response. Protein kinase C inhibition, in contrast, did not influence EGF activation of NF-kappaB.

journal_name

Oncogene

journal_title

Oncogene

authors

Sun L,Carpenter G

doi

10.1038/sj.onc.1201731

subject

Has Abstract

pub_date

1998-04-23 00:00:00

pages

2095-102

issue

16

eissn

0950-9232

issn

1476-5594

journal_volume

16

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation.

    abstract::Bruton's tyrosine kinase (BTK) is essential for B-cell proliferation/differentiation and it is generally believed that its expression and function are limited to bone marrow-derived cells. Here, we report the identification and characterization of p65BTK, a novel isoform abundantly expressed in colon carcinoma cell li...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.504

    authors: Grassilli E,Pisano F,Cialdella A,Bonomo S,Missaglia C,Cerrito MG,Masiero L,Ianzano L,Giordano F,Cicirelli V,Narloch R,D'Amato F,Noli B,Ferri GL,Leone BE,Stanta G,Bonin S,Helin K,Giovannoni R,Lavitrano M

    更新日期:2016-08-18 00:00:00

  • STAT activation by the PDGF receptor requires juxtamembrane phosphorylation sites but not Src tyrosine kinase activation.

    abstract::Activation of the platelet-derived growth factor (PDGF) receptor tyrosine kinase induces tyrosine phosphorylation of Signal Transducer and Activator of Transcription (STAT) proteins. Since the PDGF receptor also activates the Src tyrosine kinase, it is possible that Src mediates tyrosine phosphorylation of STATs in PD...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202694

    authors: Sachsenmaier C,Sadowski HB,Cooper JA

    更新日期:1999-06-17 00:00:00

  • Pituitary tumour transforming gene (PTTG) induces genetic instability in thyroid cells.

    abstract::Cancer reflects the progressive accumulation of genetic alterations and subsequent genetic instability of cells. Cytogenetic studies have demonstrated the importance of aneuploidy in differentiated thyroid cancer development. The pituitary tumour transforming gene (PTTG), also known as securin, is a mitotic checkpoint...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208659

    authors: Kim D,Pemberton H,Stratford AL,Buelaert K,Watkinson JC,Lopes V,Franklyn JA,McCabe CJ

    更新日期:2005-07-14 00:00:00

  • Canonical ErbB-2 isoform and ErbB-2 variant c located in the nucleus drive triple negative breast cancer growth.

    abstract::Triple negative breast cancer (TNBC) refers to tumors that do not express clinically significant levels of estrogen and progesterone receptors, and lack membrane overexpression or gene amplification of ErbB-2/HER2, a receptor tyrosine kinase. Transcriptome and proteome heterogeneity of TNBC poses a major challenge to ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-020-01430-9

    authors: Chervo MF,Cordo Russo RI,Petrillo E,Izzo F,De Martino M,Bellora N,Cenciarini ME,Chiauzzi VA,Santa María de la Parra L,Pereyra MG,Güttlein LN,Podhajcer OL,Daniotti JL,Dupont A,Barchuk S,Figurelli S,Lopez Della Vecchia D,

    更新日期:2020-09-01 00:00:00

  • The PI 3-kinase-Rac-p38 MAP kinase pathway is involved in the formation of signet-ring cell carcinoma.

    abstract::Signet-ring cell carcinoma is classified in poorly differentiated adenocarcinoma with an aggressive nature and a poor prognosis. We have shown that the activation of PI 3-kinase in highly differentiated adenocarcinomas induces loss of cell-cell contact and formation of vacuoles, giving phenotypes similar to those of s...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206796

    authors: Xu Q,Karouji Y,Kobayashi M,Ihara S,Konishi H,Fukui Y

    更新日期:2003-08-28 00:00:00

  • TIPUH1 encodes a novel KRAB zinc-finger protein highly expressed in human hepatocellular carcinomas.

    abstract::To achieve a better understanding of mechanisms that underlie hepatocarcinogenesis and to identify novel target molecules for diagnosis and therapy of hepatocellular carcinoma (HCC), we previously analysed gene-expression profiles of 20 HCC tissues on a cDNA microarray. Among the genes upregulated in the tumor tissues...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209517

    authors: Silva FP,Hamamoto R,Furukawa Y,Nakamura Y

    更新日期:2006-08-17 00:00:00

  • Retrogenic expression of the MET proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas.

    abstract::The MET oncogene encodes the receptor for HGF/Scatter Factor, known to control cell motility and invasion in epithelial cells. We report that the Met/HGF receptor, absent in differentiated adult skeletal muscles, is aberrantly expressed in clinical samples and in established cell lines of human rhadbomyosarcomas. In b...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Ferracini R,Olivero M,Di Renzo MF,Martano M,De Giovanni C,Nanni P,Basso G,Scotlandi K,Lollini PL,Comoglio PM

    更新日期:1996-04-18 00:00:00

  • Upregulation of IKKalpha/IKKbeta by integrin-linked kinase is required for HER2/neu-induced NF-kappaB antiapoptotic pathway.

    abstract::Constitutively active HER2/neu activates nuclear factor kappa-B (NF-kappaB) in cells and induces their resistance to apoptotic stimuli such as tumor necrosis factor-alpha (TNF-alpha). Here, we show that integrin-linked kinase (ILK), the crucial signal transducer in the integrin pathway, is involved in HER2/neu-mediate...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207485

    authors: Makino K,Day CP,Wang SC,Li YM,Hung MC

    更新日期:2004-05-06 00:00:00

  • Functional interactions within adenovirus E1A protein complexes.

    abstract::The transforming potential of adenovirus E1A oncogene products derives largely from the formation of complexes with cellular proteins, including the p105Rb tumor suppressor and a related p107 species, p130 and p300 proteins, and cyclin A (p60cycA). Extensive quantitative analyses using E1A deletion mutants identified ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Barbeau D,Charbonneau R,Whalen SG,Bayley ST,Branton PE

    更新日期:1994-02-01 00:00:00

  • Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates.

    abstract::The motility of cancer cells in 3D matrices is of two types: mesenchymal motility, in which the cells are elongated and amoeboid motility, in which the cells are round. Amoeboid motility is driven by an actomyosin-based contractile force, which is regulated by the Rho/ROCK pathway. However, the molecular mechanisms un...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2009.2

    authors: Yamazaki D,Kurisu S,Takenawa T

    更新日期:2009-04-02 00:00:00

  • Evidence for GEAPS, novel Glial E2F1-Associated Proteins in hamster glioma cells induced by the human neurotropic polyomavirus, JCV.

    abstract::Injection of the human neurotropic polyomavirus, JCV, into neonatal hamsters causes tumors of glial origin. Previously, a rapidly proliferating cell line, HJC-15, which expresses high levels of the viral T-antigen, had been established from JCV-induced hamster glial tumors. In our analyses of the mechanisms involved i...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Raj GV,Ansari SA,Khalili K

    更新日期:1996-03-21 00:00:00

  • Development of cellular resistance to pp60v-src kinase-induced cell death.

    abstract::The v-src gene of Rous sarcoma virus (RSV) encodes pp60v-src, a tyrosine kinase that can initiate cellular transformation. High levels of v-src gene expression can either be cytotoxic or the cause of altered expression of cellular genes. Examination of cytotoxic thresholds is difficult because cells expressing high le...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Wu LW,Hackett PB

    更新日期:1995-10-19 00:00:00

  • Tumour regression in a ligand inducible manner mediated by a chimeric tumour suppressor derived from p53.

    abstract::The p53 tumour suppressor induces cell cycle arrest and apoptosis in response to cellular stresses. p53 is inactivated by various cellular and viral factors. We set out to generate regulatable p53 derivatives that are highly inducible by synthetic ligands, escape inactivation and efficiently induce apoptosis. We have ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1203256

    authors: Sengupta S,Ralhan R,Wasylyk B

    更新日期:2000-01-20 00:00:00

  • Impact of G₂ checkpoint defect on centromeric instability.

    abstract::Centromeric instability is characterized by dynamic formation of centromeric breaks, deletions, isochromosomes and translocations, which are commonly observed in cancer. So far, however, the mechanisms of centromeric instability in cancer cells are still poorly understood. In this study, we tested the hypothesis that ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.508

    authors: Deng W,Tsao SW,Mak GW,Tsang CM,Ching YP,Guan XY,Huen MS,Cheung AL

    更新日期:2011-03-17 00:00:00

  • Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells.

    abstract::The natural phytoalexin resveratrol (3, 5, 4'-trihydroxystilbene) exhibits both chemopreventive and antitumor activities through a variety of mechanisms. We have shown previously that resveratrol-induced apoptosis of a human colon cancer cell line involved the redistribution of CD95 (Fas/Apo-1) into lipid rafts. Here,...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208086

    authors: Delmas D,Rébé C,Micheau O,Athias A,Gambert P,Grazide S,Laurent G,Latruffe N,Solary E

    更新日期:2004-11-25 00:00:00

  • The NF2 tumor suppressor merlin interacts with Ras and RasGAP, which may modulate Ras signaling.

    abstract::Inactivation of the tumor suppressor NF2/merlin underlies neurofibromatosis type 2 (NF2) and some sporadic tumors. Previous studies have established that merlin mediates contact inhibition of proliferation; however, the exact mechanisms remain obscure and multiple pathways have been implicated. We have previously repo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0883-6

    authors: Cui Y,Groth S,Troutman S,Carlstedt A,Sperka T,Riecken LB,Kissil JL,Jin H,Morrison H

    更新日期:2019-09-01 00:00:00

  • Involvement of cdc2-mediated phosphorylation in the cell cycle-dependent regulation of p185neu.

    abstract::We previously reported cell cycle-dependent negative regulation of p185neu (decreased tyrosine phosphorylation and kinase activity, with electrophoretic mobility retarded by serine/threonine phosphorylation) in M phase and the escape of mutation-activated p185neu* from this regulation. Our present results showed that ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1201442

    authors: Kiyokawa N,Karunagaran D,Lee EK,Xie Y,Yan DH,Hung MC

    更新日期:1997-11-27 00:00:00

  • HBx regulates transcription factor PAX8 stabilization to promote the progression of hepatocellular carcinoma.

    abstract::Transcription factor PAX8 expression is upregulated in several types of cancers. However, little is known about the function of PAX8 in the progression of hepatoma and its regulatory mechanisms. Here, we show that PAX8 silencing inhibits the proliferation and clonogenicity of hepatoma cells and its growth in vivo. The...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0907-2

    authors: Wang J,Li N,Huang ZB,Fu S,Yu SM,Fu YM,Zhou PC,Chen RC,Zhou RR,Huang Y,Hu XW,Fan XG

    更新日期:2019-10-01 00:00:00

  • MUC1-C activates BMI1 in human cancer cells.

    abstract::B-cell-specific Moloney murine leukemia virus integration site 1 (BMI1) is a component of the polycomb repressive complex 1 (PRC1) complex that is overexpressed in breast and other cancers, and promotes self-renewal of cancer stem-like cells. The oncogenic mucin 1 (MUC1) C-terminal (MUC1-C) subunit is similarly overex...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2016.439

    authors: Hiraki M,Maeda T,Bouillez A,Alam M,Tagde A,Hinohara K,Suzuki Y,Markert T,Miyo M,Komura K,Ahmad R,Rajabi H,Kufe D

    更新日期:2017-05-18 00:00:00

  • Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes.

    abstract::Alternative splicing is a widespread process contributing to structural transcript variation and proteome diversity. In cancer, the splicing process is commonly disrupted, resulting in both functional and non-functional end-products. Cancer-specific splicing events are known to contribute to disease progression; howev...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2015.318

    authors: Sveen A,Kilpinen S,Ruusulehto A,Lothe RA,Skotheim RI

    更新日期:2016-05-12 00:00:00

  • PCAF is an HIF-1alpha cofactor that regulates p53 transcriptional activity in hypoxia.

    abstract::The p53 tumour suppressor is involved in several crucial cellular functions including cell-cycle arrest and apoptosis. p53 stabilization occurs under hypoxic and DNA damage conditions. However, only in the latter scenario is stabilized p53 capable of inducing the expression of its pro-apoptotic targets. Here we presen...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.192

    authors: Xenaki G,Ontikatze T,Rajendran R,Stratford IJ,Dive C,Krstic-Demonacos M,Demonacos C

    更新日期:2008-10-02 00:00:00

  • Paclitaxel-induced apoptosis in BJAB cells proceeds via a death receptor-independent, caspases-3/-8-driven mitochondrial amplification loop.

    abstract::Caspase-8 is a key effector of death-receptor-triggered apoptosis. In a previous study, we demonstrated, however, that caspase-8 can also be activated in a death receptor-independent manner via the mitochondrial apoptosis pathway, downstream of caspase-3. Here, we show that caspases-3 and -8 mediate a mitochondrial am...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206280

    authors: von Haefen C,Wieder T,Essmann F,Schulze-Osthoff K,Dörken B,Daniel PT

    更新日期:2003-04-17 00:00:00

  • Regulation of lineage restricted haemopoietic transcription factors in cell hybrids.

    abstract::SCL, GATA-1, GATA-2 and GATA-3 encode lineage restricted haemopoietic transcription factors. We have previously shown that SCL, GATA-1 and GATA-2 are expressed in multipotent progenitors prior to lineage commitment, but are down-regulated during granulocyte/monocyte differentiation. The phenomenon of gene extinction i...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Murrell AM,Green AR

    更新日期:1995-02-16 00:00:00

  • Proviral integrations at the Evi5 locus disrupt a novel 90 kDa protein with homology to the Tre2 oncogene and cell-cycle regulatory proteins.

    abstract::Evi5 is a common site of retroviral integration in T-cell lymphomas of AKXD mice. Mapping studies have localized Evi5 to a region approximately 18 kb upstream of another common viral integration site, Gfi1, on mouse chromosome 5 (Liao X, Jenkins NA and Copeland NG, (1995a). J. Virol., 69, 7132-7137). Gfi1 encodes a zi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1200929

    authors: Liao X,Du Y,Morse HC 3rd,Jenkins NA,Copeland NG

    更新日期:1997-03-06 00:00:00

  • High-resolution, dual-platform aCGH analysis reveals frequent HIPK2 amplification and increased expression in pilocytic astrocytomas.

    abstract::Pilocytic astrocytomas (PAs, WHO grade I) are the most common brain tumors in the pediatric and adolescent population, accounting for approximately one-fifth of central nervous system tumors. Because few consistent molecular alterations have been identified in PAs compared to higher grade gliomas, we performed array c...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2008.110

    authors: Deshmukh H,Yeh TH,Yu J,Sharma MK,Perry A,Leonard JR,Watson MA,Gutmann DH,Nagarajan R

    更新日期:2008-08-07 00:00:00

  • Cooperative activity between HER oncogenes and the tumor suppressor IRF-1 results in apoptosis.

    abstract::The tumor suppressor transcription factor IRF-1 inhibits cell growth. In this report we show that IRF-1 also induces apoptosis of highly transformed and tumorigenic cell lines. This activity of IRF-1 is demonstrated with cell lines expressing HER oncogenes and an activatable IRF-1 fusion protein. Growth of cell lines ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202704

    authors: Kirchhoff S,Hauser H

    更新日期:1999-06-24 00:00:00

  • Structure and regulation of Src family kinases.

    abstract::Src family kinases are prototypical modular signaling proteins. Their conserved domain organization includes a myristoylated N-terminal segment followed by SH3, SH2, and tyrosine kinase domains, and a short C-terminal tail. Structural dissection of Src kinases has elucidated the canonical mechanisms of phosphotyrosine...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1208081

    authors: Boggon TJ,Eck MJ

    更新日期:2004-10-18 00:00:00

  • Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer.

    abstract::Neoadjuvant and adjuvant chemotherapies provide survival benefits to breast cancer patients, in particular in estrogen receptor negative (ER-) cancers, by reducing rates of recurrences. It is assumed that the benefits of (neo)adjuvant chemotherapy are due to the killing of disseminated, residual cancer cells, however,...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0624-2

    authors: Lan Q,Peyvandi S,Duffey N,Huang YT,Barras D,Held W,Richard F,Delorenzi M,Sotiriou C,Desmedt C,Lorusso G,Rüegg C

    更新日期:2019-04-01 00:00:00

  • Nuclear FGF-2 facilitates cell survival in vitro and during establishment of metastases.

    abstract::Nuclear-targeted high molecular weight 24 kDa fibroblast growth factor 2 (FGF-2) may induce specific cell functions through intracrine mechanisms. The role of nuclear FGF-2 on the metastatic potential of carcinoma cells was examined by conditional FGF-2 expression, which demonstrated that spontaneous metastasis in nud...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207638

    authors: Thomas-Mudge RJ,Okada-Ban M,Vandenbroucke F,Vincent-Salomon A,Girault JM,Thiery JP,Jouanneau J

    更新日期:2004-06-10 00:00:00

  • Patterns of expression of chromosome 17 genes in primary cultures of normal ovarian surface epithelia and epithelial ovarian cancer cell lines.

    abstract::Oligonucleotide microarray analysis was applied to assess the expression profile of 332 probe sets representing 308 genes or expressed sequence tags (ESTs) that map to chromosome 17 in order to address epigenetic events that result in alterations in gene expression in epithelial ovarian cancer (EOC). Expression profil...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206219

    authors: Presneau N,Mes-Masson AM,Ge B,Provencher D,Hudson TJ,Tonin PN

    更新日期:2003-03-13 00:00:00